Methodologies for quantifying the results of intravesical chemotherapy of superficial tumors of the bladder
Authors:
- 1 December 1985
- journal article
- research article
- Published by Springer Nature in Medical Oncology and Tumor Pharmacotherapy
- Vol. 2 (4) , 249-254
Abstract
Various evaluation methods exist to report results of installation therapy on superficial urinary bladder cancer. The following three, based on material previously gathered from 30 patients treated with adriamycin instillations, are analysed in this study: (1) The graphic expression method which covers the most necessary details, but demands space and does not permit adequate statistical analysis. (2) Evaluating the terms usually used in oncology, i.e. complete response (CR), partial response (PR), total response (TR), no change and progression. These are suitable for statistical analysis and are of crucial relevance in the study of carcinomain situ TIS. In Ta-1 cancers however, these terms (CR, etc.) are not descriptive of time, and since their results depend completely on the choice of endpoints they do not permit realistic statistical analysis. (3) Determining indices (Ri/m, Ri/c) and recurrence rates (RR, MARR, MTBR) in Ta-1 cancers. These factors take into consideration both the time variable and multicentricity in space and time, making rigorous statistical analysis possible. In our opinion Ri/c states most accurately a patient’s clinical course.Keywords
This publication has 13 references indexed in Scilit:
- Long-Term Mitomycin C Instillation After Transurethral Resection of Superficial Bladder Carcinoma: Influence on Recurrence, Progression and SurvivalJournal of Urology, 1984
- Die Behandlung von Carcinoma in situ der Harnblase mit lokaler AdriamycininstillationAktuelle Urologie, 1984
- Topical Doxorubicin Hydrochloride Therapy for Carcinoma in Situ of the Bladder: A FollowupJournal of Urology, 1984
- Does Intravesical Chemotherapy Prevent Invasive Bladder Cancer?Journal of Urology, 1984
- ADRIAMYCIN INSTILLATIONS AS RECURRENCE PROPHYLAXIS IN SUPERFICIAL URINARY-BLADDER CANCER1984
- Intravesical Adriamycin Therapy in Carcinoma in Situ of the Urinary BladderScandinavian Journal of Urology and Nephrology, 1984
- Prophylactic Chemotherapy of Superficial Transitional Cell Bladder Carcinoma: an EORTC Randomized Trial Comparing Thiotepa, an Epipodophyllotoxin (VM26) and TUR AloneEuropean Urology, 1982
- Stellenwert der Blasenteilresektion zur Therapie des BlasentumorsAktuelle Urologie, 1980
- THIOTEPA IN THE TREATMENT OF TUMOURS OF THE BLADDERThe Lancet, 1961
- Papillomata of Bladder Treated with PodophyllinBMJ, 1948